Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial
European Journal of Sport Science · 2026-04 · 26 (4)
DOI: 10.1002/ejsc.70155 ↗At a glance
Randomisierte kontrollierte Studie in European Journal of Sport Science, published online on 2026-03-12. Written by Jocelito Bijoldo Martins and 3 co-authors. Institution: Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil. Major MEDLINE topics: Muscle Strength, Gliclazide, Resistance Training, Athletic Performance. 57 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
To examine the acute effect of gliclazide on exercise performance and recovery of muscle strength in healthy participants. We conducted a randomized, double‐blind, placebo‐controlled crossover clinical trial in 44 strength‐trained men. They were allocated to gliclazide modified release (MR) (90 mg, 8h before exercise sessions) or placebo, undergo three consecutive sessions of strength exercise (four sets, 80% of one‐repetition maximum [1‐RM] of bench press and free squat exercise). We evaluated total volume‐load (VL) (#repetitions x 80%1‐RM), range of motion (ROM), insulin and glucose levels, creatine kinase MM (CK‐MM), lactate dehydrogenase (LDH), interleukin‐6 (IL‐6) and tumor necrosis factor alpha (TNF‐α), hemodynamic parameters, perceived muscle soreness and recovery scores. Gliclazide enhanced strength exercise performance with improvements in total VL (bench press 23.3%, p < 0.001; squat 23.2%, p < 0.001), and improved muscle recovery 24–48h post‐exercise: ROM (shoulder 1.1%, p < 0.001; knee 1.6%, p = 0.004), CK‐MM (−13.2%, p < 0.001), LDH (−12.8%, p < 0.001), TNF‐α (−17.4%, p < 0.001), IL‐6 (−5.3%, p < 0.001), muscle soreness (−17.7%, p < 0.001) and recovery scores (32.5%, p = 0.001). However, hypoglycemia events were observed in 3 participants in the gliclazide group. In conclusion, Gliclazide MR 90 mg, 8h before strength exercise, produced ergogenic effects (exercise performance and muscle recovery), although hypoglycemia was observed in 7% of subjects. Registration : “ www.clinicaltrials.gov ”, “NCT04443777” (Primary Completion: 01/08/2020; Study Completion: 31/10/2023)
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, RS, Brazil.
- Programa de Pos-Graduação em Saúde Coletiva, Universidade do Vale do Rio dos Sinos, São Leopoldo, Rio Grande do Sul, Brazil.
- Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
- Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
ORCID profiles: Alexandre Machado Lehnen
Cite
APA
Martins, J. B., Dipp, T., Schaan, B. D., & Lehnen, A. M. (2026). Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial. European Journal of Sport Science, 26(4). https://doi.org/10.1002/ejsc.70155
Vancouver
Martins JB, Dipp T, Schaan BD, Lehnen AM. Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial. European Journal of Sport Science. 2026;26(4). doi:10.1002/ejsc.70155
BibTeX
@article{Martins2026,
author = {Martins, Jocelito Bijoldo and Dipp, Thiago and Schaan, Beatriz D and Lehnen, Alexandre Machado},
title = {Gliclazide Enhances Exercise Performance and Recovery of Muscle Strength in Healthy Trained Individuals: A Randomized Controlled Trial},
journal = {European Journal of Sport Science},
year = {2026},
volume = {26},
number = {4},
doi = {10.1002/ejsc.70155}
}
EUVIMED